Fresenius Medical Care AG (FMS) to Issue Annual Dividend of $0.79 on June 6th

Fresenius Medical Care AG (NYSE:FMS) announced an annual dividend on Friday, May 9th, Wall Street Journal reports. Investors of record on Friday, May 23rd will be given a dividend of 0.7871 per share on Friday, June 6th. This represents a yield of 1.9%. The ex-dividend date is Friday, May 23rd. This is a 80.1% increase from Fresenius Medical Care’s previous annual dividend of $0.44.

Fresenius Medical Care has decreased its dividend by an average of 8.2% annually over the last three years. Fresenius Medical Care has a dividend payout ratio of 27.5% indicating that its dividend is sufficiently covered by earnings. Analysts expect Fresenius Medical Care to earn $1.92 per share next year, which means the company should continue to be able to cover its $0.63 annual dividend with an expected future payout ratio of 32.8%.

Fresenius Medical Care Price Performance

FMS stock opened at $28.37 on Friday. The company’s 50-day moving average price is $24.55 and its two-hundred day moving average price is $23.43. The firm has a market cap of $16.65 billion, a P/E ratio of 23.45, a P/E/G ratio of 0.76 and a beta of 0.85. The company has a quick ratio of 1.02, a current ratio of 1.37 and a debt-to-equity ratio of 0.42. Fresenius Medical Care has a 12 month low of $17.93 and a 12 month high of $28.59.

Fresenius Medical Care (NYSE:FMS) last announced its quarterly earnings data on Tuesday, May 6th. The company reported $0.44 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.43 by $0.01. Fresenius Medical Care had a net margin of 3.43% and a return on equity of 6.04%. The business had revenue of $5.54 billion for the quarter, compared to analysts’ expectations of $4.71 billion. On average, analysts anticipate that Fresenius Medical Care will post 1.51 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Separately, StockNews.com upgraded Fresenius Medical Care from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, February 5th.

Fresenius Medical Care Company Profile

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.